← Open Payments lookup

JESMONEET BOBB-DIALLO: Open Payments

NPI 1669917605 · LIVERPOOL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,523 in 49 payments from 9 companies in 2025. Trend: 2023 $22 · 2024 $74 · 2025 $1,523

Food & beverage: $1,523
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.12$410
Alkermes, Inc.11$368
Braeburn Inc.7$217
Otsuka America Pharmaceutical, Inc.7$146
Luye Pharma (USA) Ltd.3$144
Gilead Sciences, Inc.1$112
Teva Pharmaceuticals USA, Inc.6$94
Supernus Pharmaceuticals, Inc.1$16
Orexo US, Inc.1$15

Products named: COBENFY, BRIXADI, ARISTADA, ERZOFRI EXTENDED-RELEASE, ABILIFY ASIMTUFII, LYBALVI, Epclusa, UZEDY.

Industry payments across NY — which companies pay providers there.